Kate Haviland
Insider
IndividualSelling only3 10b5-1 trades
- 2024
- Jul 2, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kate Haviland files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- SR ONE CAPITAL MANAGEMENT, LLC - $10.00M in AVLN purchases and sales in the last 12 months
- Novo Holdings A/S - $10.00M in AVLN purchases and sales in the last 12 months
- Jill Carroll - $5.00M in AVLN purchases and sales in the last 12 months
- Ryan Cohlhepp - $3.46M in BCAX purchases and sales in the last 12 months
- Claire Mazumdar - $3.14M in BCAX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kate Haviland?
Kate Haviland is a corporate insider of Fulcrum Therapeutics, Inc. (FULC). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kate Haviland last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 5 filings going back to 2024.
Has Kate Haviland been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($227K) across all tracked filings.
